Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Oct 12;18(10):2131.
doi: 10.3390/ijms18102131.

Association between Stress and the HPA Axis in the Atopic Dermatitis

Affiliations
Review

Association between Stress and the HPA Axis in the Atopic Dermatitis

Tzu-Kai Lin et al. Int J Mol Sci. .

Abstract

The hypothalamic-pituitary-adrenal (HPA) axis is one of the body's neuroendocrine networks that responds to psychological stress (PS). In the skin, there exists a peripheral HPA axis similar to the central axis. Glucocorticoids (GCs) are key effector molecules of the HPA axis and are essential for cutaneous homeostasis. Atopic dermatitis (AD) is a condition typically characterized by a chronic relapsing course that often results in PS. HPA dysfunction is present in AD patients by the decreased response of GCs elevation to stress as compared to those unaffected by AD. Nevertheless, in skin, acute PS activates several metabolic responses that are of immediate benefit to the host. During the acute phase of PS, increased endogenous GCs have been shown to provide benefit rather than by aggravating cutaneous inflammatory dermatoses. However, a chronic T helper cell type 2 (Th2) predominant cytokine profile acts as a negative feedback loop to blunt the HPA axis response in AD. In this article, we reviewed the role of CRF, pro-opiomelanocortin (POMC)-derived peptides, GCs of the HPA, and 11β-hydroxysteroid dehydrogenase 1 (11β-HSD1) in AD, with a discussion of the pathogenetic mechanisms of inflammation and skin barrier functions, including antimicrobial defense, and their association with PS.

Keywords: HPA axis; atopic dermatitis; glucocorticoid; inflammation; psychological stress; skin barrier.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Schematic representation of the Hypothalamic-Pituitary-Adrenal (HPA) axis in the skin. The effects on keratinocytes (left diagram) on AD skin in regards to skin barrier structure and inflammatory response (right diagram). The central HPA axis and the peripheral HPA axis both regulate skin barrier homeostasis and the inflammatory response in the skin. Peripheral nerve endings in the skin are represented in green, whereas dermal capillaries are shown in red. Transepidermal water loss (TEWL) is represented by curled blue lines (right diagram). Corticotrophin-releasing hormone receptor type 1 (CRH-R1); Glucocorticoid receptor (GR); Melanocortin receptor type 1 and 2 (MCR1 and MCR2); 11 beta-hydroxysteroid dehydrogenase 1 (11β-HSD1).
Figure 2
Figure 2
Interactions between the central HPA axis and the cutaneous HPA axis and the effects on the skin barrier and dermatitis. The main hormones, neurotransmitters, and cytokines are highlighted in yellow. Solid arrows represent direct effect of hormones and neurotransmitters related to the HPA axis, whereas dashed lines indicate the influence of psychological stress on other hormones and neurotransmitters that are different from the HPA axis and linked to epidermal homeostasis.

References

    1. Bieber T. Atopic dermatitis. N. Engl. J. Med. 2008;358:1483–1494. doi: 10.1056/NEJMra074081. - DOI - PubMed
    1. Elias P.M., Wakefield J.S. Therapeutic implications of a barrier-based pathogenesis of atopic dermatitis. Clin. Rev. Allergy Immunol. 2011;41:282–295. doi: 10.1007/s12016-010-8231-1. - DOI - PMC - PubMed
    1. Irvine A.D.M., Eichenfield L.F.M., Friedlander S.F.M., Simpson E.L.M.M. Review of critical issues in the pathogenesis of atopic dermatitis. Semin. Cutan. Med. Surg. 2016;35:S89–S91. doi: 10.12788/j.sder.2016.042. - DOI - PubMed
    1. Ohtsu H., Seike M. Histamine and histamine receptors in allergic dermatitis. Handb. Exp. Pharmacol. 2017;241:333–345. - PubMed
    1. Senra M.S., Wollenberg A. Psychodermatological aspects of atopic dermatitis. Br. J. Dermatol. 2014;170:38–43. doi: 10.1111/bjd.13084. - DOI - PubMed

LinkOut - more resources